Managing overdose risks and compensation with naloxone
Overdose Risk Management and Compensation in the Era of Naloxone
['FUNDING_R01'] · NEW YORK UNIVERSITY · NIH-10408121
This study is looking at how people who use opioids, especially those not in formal programs, get and use naloxone, the medication that can reverse an overdose, to find out what they know and what they need to help improve access and education about it.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10408121 on ClinicalTrials.gov |
What this research studies
This research investigates how naloxone, an overdose reversal medication, is distributed and used among opioid users, particularly those not connected to formal overdose prevention programs. It aims to identify gaps in knowledge and access to naloxone, as well as to explore the behavioral and psychosocial effects of surviving an overdose. By understanding these factors, the research seeks to improve overdose education and naloxone distribution efforts. The study will involve collecting data from various populations to assess their experiences and attitudes towards naloxone.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults aged 21 and older who use opioids or are at risk of opioid overdose.
Not a fit: Patients who do not use opioids or are not at risk of overdose may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for naloxone distribution and education, ultimately reducing opioid overdose deaths.
How similar studies have performed: Previous research has shown that naloxone distribution initiatives can save lives, indicating that this approach has potential for success.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BENNETT, ALEXANDER S — NEW YORK UNIVERSITY
- Study coordinator: BENNETT, ALEXANDER S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.